WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Trump touts drug pricing pact with Regeneron aimed at lowering costs

Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump administration.

Raccontata dacnbc.comupi.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
usatoday.comStai leggendo2 mesi fa

Trump touts drug pricing pact with Regeneron aimed at lowering costs

Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump administration.

originale
upi.com2 mesi fa

Trump promotes new drug price deal with Regeneron - UPI.com

On Thursday, President Donald Trump announced a new drug price deal with Regeneron, the latest company to agree to a new price policy push.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 23 aprile 2026·cnbc.com

    Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

    Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

  2. venerdì 24 aprile 2026·upi.com

    Trump promotes new drug price deal with Regeneron - UPI.com

    On Thursday, President Donald Trump announced a new drug price deal with Regeneron, the latest company to agree to a new price policy push.

cnbc.com2 mesi fa

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

Leggi questa versione → originale